T oll-like receptors play critical roles in innate immunity and host defense. They detect invading pathogens through recognition of pathogen-associated molecular patterns (PAMPs) such as LPSs, nucleic acids, lipoproteins, and glycans derived from pathogens and initiate the activation of multiple intracellular signaling pathways (1) . Among these pathways, NFkB and MAPK pathways are most important (2) . Activation of the NF-kB and MAPK pathways leads to induction of cytokines and chemokines, which shape the nature, magnitude, and duration of host proinflammatory and innate immune responses (3) . Although full activation of TLR signaling is essential for host defense, dysregulation of this process contributes to many inflammatory diseases and immunopathologic disorders, such as endotoxin shock and autoimmune disease (2) . It is important to elucidate the underlying molecular mechanism through which the TLR response is tightly regulated. For example, previous studies identified positive regulators of the TLR pathway, such as the, Peli1, Nrdp1, and MHC class II molecules (4) (5) (6) , and negative regulators such as NLRC3, SHP-2, and MHC class I molecules (7) (8) (9) ; however, it remains to be explored whether there are other unidentified regulators for TLR responses.
Protein phosphorylation and dephosphorylation, mediated by a plethora of protein kinases and phosphatases, are important regulatory mechanisms in a wide variety of biological processes, such as cell development, differentiation, and transformation in higher eukaryotes. It is reported that in TLR-activated macrophage, most phosphorylation sites were on serine (84%) and threonine residues (14%), whereas tyrosine phosphorylation occurred only in 2% of the cases (10) . The human genome encodes ∼40 catalytic subunits of Ser/Thr phosphatases (11) , which include the PP1, PP2A/PP2, PP2B/calcineurin/PP3, PP4, PP5, PP6, and PP7 of the PPP phosphatase subfamily (12) . PP1 is one of the most abundant phosphatases, and it has important regulatory roles in cellular events [e.g., metabolism, gene transcription, cell polarity, vesicle trafficking and cell cycle (13) ]. PP1 holoenzymes typically function as heterodimeric complexes containing one catalytic subunit and one regulatory subunit (14) . Human genome encodes three PP1 catalytic subunits-PPP1Ca, PPP1Cb, and PPP1Cg (15) . So far, ∼180 human proteins have been identified as PP1 regulatory subunits (16) . Among these regulatory subunits, PPP1r14a, PPP1r14b, PPP1r15a/GADD34 (17) , PPP1r15b, PPP1R18, and Klraq1 are highly expressed in immune cells and thus might be involved in regulation of immune responses. The regulatory subunits may inhibit PP1 enzymatic activity, restrict its substrate specificity, or limit its subcellular localization. Studies have shown that PP1 together with GADD34 dephosphorylates IKK via adaptor protein CUEDC2, thus negatively regulating the TNF-R pathway (18) . However, the roles of PP1 in TLR-mediated innate immunity have not been studied.
In TLRs and IL-1R signaling, activation of NF-kB and MAPK kinases requires a critical upstream kinase TAK1 (tumor growth factor b-activated kinase), a member of the MAP kinase kinase kinase family (19) . TAK1 exists in cells as a stable complex with two structural subunits TAB1 and TAB2 (or TAB3, the TAB2 homolog). Activation of TAK1 correlates with phosphorylation of residues Thr178, Thr184, Thr187, and Ser192 in its activation loop (20, 21) . In particular, phosphorylation of Thr187 is required for TAK1 kinase activation, which is increased in response to stimulation by proinflammatory cytokines and TLR ligands (20) . Phosphorylation of TAK1 at sites other than those in the activation loop has also been reported in the literature (22, 23) and the PhosphoSitePlus Web site (http://www.phosphosite.org/); however, whether these phosphorylation events regulate TAK1 activation remains to be determined.
In the current study, we have demonstrated that protein phosphates PP1, together with its regulatory subunit GADD34, negatively regulate TLR-triggered inflammatory cytokine production in macrophages by specifically dephosphorylating TAK at serine 412. Mutation of TAK1 Ser412 phosphorylation inhibited IL-1R and TLR-mediated signaling and proinflammatory cytokine production. PP1 and GADD34 knockdown enhanced LPS-induced TAK1 Ser412 phosphorylation without affecting the phosphorylation of Thr187 residue, and downstream NF-kB and MAPK activation, resulting in increased proinflammatory cytokine production in macrophages. Furthermore, tautomycetin, a specific inhibitor of PP1, aggravated LPS-induced endotoxin shock in mice. These data demonstrated that PP1 inhibited TLR signaling by control TLR-induced TAK1 Serine 412 phosphorylation, thus serving as an important negative regulator of TLR-mediated immune responses. Our results brought new insight into the mechanism of the fine-tuning of TLRtriggered innate immune responses. In addition, our results would greatly benefit the improvement of the current knowledge of TAK1-mediated immune responses.
Materials and Methods

Abs, reagents, and plasmids
Abs for phospho-TAK1 Thr187, TAK1 Ser412, IRAK1, IKKa/b, IkBa, JNK, ERK1/2, and p38 were purchased from Cell Signaling Technology. Ab against PP1 and GADD34 was purchased from Santa Cruz. Ab against TAK1 was purchased from Epitomics. Anti-Flag, Myc, HA, His, and GST Abs were purchased from Abmart. Anti-Flag (M2) agarose beads were from Sigma. Recombinant human IL-1b was purchased from PeproTech. Okadaic acid was obtained from Beyotime, and Tautomycetin was obtained from Santa Cruz Biotechnology. CpG oligodeoxynucleotide (ODN) 1826, LPS (0111:B4) and polyinosinic-polycytidylic acid (poly-IC) were obtained from Sigma. Expression plasmids encoding Flag-TAK1, Flag-IKKb, Flag-TRAF6, HA-TAB1, PP1, and GADD34 were amplified by PCR and ligated into pcDNA3.1-Flag/Myc to generate Flag-or Myc-tagged expression constructs, respectively. Mutants of TAK1, PP1, and GADD34 were generated using the QuikChange Site-Directed Mutagenesis protocol (Stratagene).
Cell culture, transfection, immunoprecipitation, and Western blotting RAW264.7, HEK293T, and MEFs were obtained from American Type Culture Collection and grown in DMEM supplemented with 10% FBS. Bone marrow-derived macrophages and peritoneal macrophages were cultured with RPMI 1640 supplemented with 10% FBS. RAW264.7, HEK293T, and HeLa cells were transfected according to the manufacturer's protocol with JetPEI (Polyplus). TAK1
2/2 MEFs were a gift from Dr. H Xiao (Institute Pasteur of Shanghai, Chinese Academy of Sciences, China), and transfected with MEF Nucleofector Kit (Lonza). Whole cell extracts were prepared on ice with lysis buffer (Cell Signaling Technology) supplemented with protease inhibitor PMSF and phosphatase inhibitor mix. For immunoprecipitation, cells were lysed as described previously (24) .
Mice
C57BL/6 mice (6-8 wk old) were obtained from Joint Ventures Sipper BK Experimental Animal. All animal experiments were undertaken in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, with the approval of the Scientific Investigation Board of Zhejiang University.
Cloning and expression of GST-TAK1, MBP-Ppp1cc, and MBP-GADD34 cDNA encoding full-length mouse TAK1 was inserted into a modified pGEX-4T-1-GST-10His vector containing an N-terminal GST tag and a C terminal 103 His tag. Maltose-binding protein (MBP) fusion protein expression vector was modified from the pGEX-4T-1 vector mentioned above, where GST tag was replaced with N-terminal MBP tag. cDNA encoding full-length mouse Ppp1cc or Ppp1r15a (GADD34) was inserted into the modified pGEX-4T-1-MBP-10His vector. The plasmids encoding recombinant proteins were transformed into Escherichia coli BL-21/pLys strain, and then protein expression was inducted by 0.04 or 0.08 mM isopropyl b-D-thiogalactoside for 20 h at 16˚C.
GST pull-down assay
The fusion proteins of GST-TAK1, MBP-Ppp1cc, and MBP-GADD34 were expressed in E. coli and purified according to standard protocols. Approximately 3 mg GST fusion proteins bound to glutathione-agarose beads were mixed with MBP-Ppp1cc or MBP-GADD34 and incubated at 4˚C for 4 h with gentle rotation. Beads were washed three times with cell lysis buffer, and proteins bound were eluted with 13 SDS sample buffer and analyzed with Western blotting.
Small interfering RNA
PP1-and GADD34-specific small interfering RNA (siRNA) oligos were obtained from Santa Cruz Biotechnology. TAK1 siRNA oligos were synthesized by Genepharma (Shanghai, China). siRNA duplexes were transfected into RAW264.7 cells and bone marrow-derived macrophages (BMDMs) by using INTERFERin (Polyplus) or into HeLa by using RNAimax (Invitrogen) according to the manufacturer's protocol. The following sequences of siRNA oligos were used (only the sense strands were shown): human TAK1: (59-GACUUGACUGUAACUGGAAdTdT-39).
Quantitative RT-PCR
Total RNA was extracted using TRIzol (Invitrogen) according to the manufacturer's instructions. RNA was reverse transcribed using M-MLV reverse transcriptase (Takara). Quantitative PCR was performed using SYBR Green (Takara) and the ABI 7500 real-time PCR system (Applied Biosystems). The following primers were used: mouse b-Actin-F: 59-AACAGTCCGCCTAGAAGCAC-39; mouse b-Actin-R: 59-CGTTGACA-TCCGTAAAGACC-39; mouse IL-6-F: 59-AGTTGCCTTCTTGGGACT-GA-39; mouse IL-6-R: 59-TCCACGATTTCCCAGAGAAC-39; mouse TNF-a-F: 59-CTGGGACAGTGACCTGGACT-39; mouse TNF-a-R: 59-G-CACCTCAGGGAAGAGTCTG-39.
In vitro phosphatase assay
Flag-tagged TAK1 or IKKb were transiently expressed and immunoprecipitated with M2 agarose beads as the substrates. On beads, in vitro phosphatase assay was performed with PP1 purchased from New England Biolabs according to the manufacturer's instructions.
Immunoprecipitation kinase assay
In vitro kinase assay was performed as described previously (25) . Briefly, the TAK1 activity assay was carried out in 20 ml of reaction mixture containing 50 mM Tris-HCl (pH 7.5), 2 mM ATP, 5 mM MgCl 2 , MKK6 (K82A) purified from E.coli as the substrates, and TAK1 immunoprecipitated by using anti-TAK1 Ab (Epitomics) and protein A/G agarose beads from Ppp1cc or its mutant stably overexpressed RAW264.7 cells.
Statistical analysis
Unpaired, two-tailed Student t test was used to determine the statistical differences between the data sets; p # 0.05 was considered statistically significant. In the mouse endotoxin shock study, p values for differences in survival between groups were calculated by a log-rank test and analyzed for statistical significance with GraphPad Prism 4.0 software.
Results
PP1 inhibits TLR-triggered production of proinflammatory cytokines in macrophages via phosphatase activity
To explore the role of PP1 in innate immune response, we first investigated the effects of PP1 on IL-6 and TNF-a production in macrophages. Overexpression of Ppp1cc, but not Ppp1ccD278, a phosphatase activity-deficient Ppp1cc mutant (26) , significantly suppressed LPS, CpG ODN, or poly-IC-induced production of IL-6 and TNF-a in RAW264.7 cells (Fig. 1A) . Consistent with this, RNAi-based silencing of PP1 led to a substantial increase in IL-6 and TNF-a production in BMDM (Fig. 1B) and RAW264.7 cells (Supplemental Fig. 1A ) stimulated by LPS, poly-IC or CpG ODN. Quantitative PCR analysis and Western blot confirmed PP1 silencing in the RAW264.7 cells and BMDM (Supplemental Fig. 1B-C) .
Tautomycetin is a specific inhibitor of PP1 (27, 28) and has been used to study PP1 function in animal models (29) . Because the inhibition of PP1 leads to enhanced production of proinflammatory cytokines, we wanted to know the effect of PP1 inhibition by tautomycetin in an LPS challenge-based mouse model of endotoxin shock. As shown in Fig. 1C , challenged with sublethal LPS, tautomycetin-pretreated mice produced more TNF-a than control mice did. Consequently, all pretreated mice died within 1 wk after in vivo LPS administration, whereas 62.5% of control mice survived ( Fig. 1D ), suggesting that inhibition of PP1 aggravates endotoxin shock in response to sublethal LPS challenge.
PP1 inhibits TLR signaling by targeting TAK1 Ser412 phosphorylation
Next, we examined the underlying signaling mechanism by which PP1 inhibited TLR-triggered immune responses. We first observed the effect of PP1 overexpression on TLR-induced phosphorylation of MAPKs and NF-kB, which is necessary for TLR-induced proinflammatory cytokine production in RAW264.7 cells. Compared with empty vector (mock) transfection, overexpression of Ppp1cc, but not Ppp1ccD278, dramatically reduced LPS-induced phosphorylation of IKKa/b and its substrate IkBa, as well as MAPKs ( Fig. 2A) . Accordingly, in the NF-kB-based luciferase reporter assay, overexpression of MyD88, TRAF6, or TAK1/ TAB1 in 293T cells enhanced reporter activity, which was impaired by co-overexpression of Ppp1cc, but not Ppp1ccD278 (Supplemental Fig. 2A ). Furthermore, overexpression of Ppp1cc inhibited LPS-induced NF-kB reporter activity in RAW264.7 cells (Supplemental Fig. 2B ). PP1 knockdown strongly enhanced LPSinduced phosphorylation of IKKa/b, IkBa, p65, ERK, JNK, and The stable transfectants of RAW264.7 were stimulated with LPS (100 ng/ml) for the indicated time. Cell lysates were immunoprecipitated with TAK1 Ab followed by washing and on beads in vitro kinase assay by using His-MKK6 as a substrate for 30 min at 25˚C. Whole cell lysates (WCL) and assay mixtures were immunoblotted with indicated Abs. (E) RAW264.7 cells were transfected with empty vector (mock) or the indicated vectors for 36 h and then stimulated with LPS (100 ng/ ml) for the indicated time. Cell lysates were immunoblotted with indicated Abs. (F) RAW264.7 cells were transfected with the indicated vectors for 36 h and then stimulated with LPS (100 ng/ml), poly-IC (20 mg/ ml) or CpG ODN (0.3 mM) for 6 or 12 h. Secretion of IL-6 and TNF-a in the supernatant was measured with ELISA. Data are plotted as means 6 SE. All experiments were performed at least three times. *p , 0.05, **p , 0.01, ***p , 0.001 versus controls. ns, no significance. p38 in RAW264.7 cells (Fig. 2B) and NF-kB and AP-1 luciferase reporter activities (Supplemental Fig. 2C ), demonstrating that PP1 negatively regulated TLR signaling in macrophages.
Activation of NF-kB and MAPK kinases in TLR signaling critically requires upstream kinase TAK1 (19) . In the reporter assays, overexpression of TAK1 together with TAB1 activated both NF-kB and AP-1 reporter activities, which were strongly suppressed by co-overexpression of Ppp1cc. This result prompted us to investigate whether PP1 regulated LPS signaling by dephosphorylating TAK1; however, as shown in Fig. 2C , PP1 knockdown had little effect on TAK1 Thr187 phosphorylation and its upstream kinase IRAK1 phosphorylation. Although phosphorylation of Thr187 in its activation loop is required for TAK1 kinase activation. Literature and PhosphositePlus database search suggest that there are indeed multiple phosphorylation sites on TAK1. Among the sites, Ser412 phosphorylation of mouse TAK1 (mTAK1; it is Ser439 in human TAK1; Ser412 is used thereafter) caught our attention. Remarkably, Ser412 phosphorylation has been detected 92 times by mass spectrometry recorded at PhosphositePlus and analyzed in two reports (22, 23) . However in these two reports, Ser412 phosphorylation was not detected in response to LPS or other NF-kB activation stimuli. To determine whether Ser412 is phosphorylated in response to TLR activation, the Flag-TAK1 protein was purified from stably overexpressed RAW264.7 cells that were treated with LPS and then analyzed by liquid chromatography coupled with tandem mass spectrometry. The result showed that the TAK1 carries phosphorylations at Ser412 (Supplemental Fig. 2D ) and Thr187 (data not shown) after LPS treatment. We further used commercially available Abs specific to phosphorylated Ser412 (mTAK1; corresponding to Ser439 in human TAK1) of TAK1 to test whether Ser412 of TAK1 could be phosphorylated in LPS signaling. Interestingly, Ser412 of TAK1 was significantly phosphorylated after LPS stimulation, and PP1 knockdown enhanced and prolonged TAK1 Ser412 phosphorylation (Fig. 2C) . We next examined whether PP1 can inhibit TAK1 kinase activity. The endogenous TAK1 was immunoprecipitated from Ppp1cc or its mutant Ppp1ccD278-stably overexpressed RAW264.7 cells, and its kinase activity was detected using MKK (K82A) purified from E.coli as TAK1 substrate. As shown in Fig.  2D , TAK1 purified from PP1 overexpressed RAW264.7 in response to LPS stimulation showed lower kinase activity toward MKK6 when compared with the TAK1 purified from GFP or Ppp1ccD278 overexpressed transfectants, which correlates well with the lower phosphorylation level of JNK and IkBa in cell lysates of PP1 overexpressed group. We also investigated whether PP1 negatively regulated LPS signaling by dephosphorylating TAK1 at Ser412. Overexpression of Ppp1cc diminished the LPSinduced IKKa/b, IkBa, and JNK phosphorylation in RAW264.7 cells, even when co-overexpressed with TAK1 wild type (WT). However, this diminishment was almost abolished when mutant TAK1 S412D, which mimics Ser412 phosphorylation, was cooverexpressed with Ppp1cc (Fig. 2E) . Again, the suppression of TAK1-induced NF-kB and AP-1 reporter gene expression by Ppp1cc was blocked when TAK1 S412D was used (Supplemental Fig. 2E ). Accordingly, co-overexpression of Ppp1cc with TAK1 WT inhibited LPS-induced IL-6 and TNF-a production; this inhibitory effect was abolished when TAK1 S412D was used (Fig.  2F) . Collectively, PP1 negatively regulates MAPKs, NF-kB acti- The
PP1 specifically dephosphorylates TAK1 at Ser412
We next examined whether PP1 is physically associated with TAK1 in macrophage. As shown in Fig. 3A , PP1 interacted with TAK1 in resting RAW264.7 cells, but disassociated from TAK1 within 2.5 min of LPS treatment. Notably, the interaction between PP1 and TAK1 was gradually restored in 30 min. Similarly, the cycling of association, dissociation, and reassociation between PP1 and TAK1 also existed in primary BMDMs treated with LPS (Fig. 3B) . Interestingly, the LPS-induced cycling of TAK1 and PP1 interaction inversely correlated with TAK1 Ser412 phosphorylation (Figs. 3A-3B) . Simultaneously, coimmunoprecipitation experiments revealed that all three isoforms of PP1 catalytic subunit, Ppp1ca, Ppp1cb, and Ppp1cc, interacted with TAK1 (Fig. 3C-D) . More importantly, purified PP1 decreased TAK1 Ser412 phosphorylation in a dosedependent manner in an in vitro dephosphorylation assay, without showing effect on Thr187 phosphorylation (Fig. 3E) , and it had a slight effect on IKKb Ser177/181 phosphorylation (Supplemental 
GADD34 mediates TAK1 Ser412 dephosphorylation by PP1
PP1 functions as a heterodimer with one of over 180 regulatory subunits that specify its location and substrates and regulate its enzymatic activity (31) . To look for the putative regulatory subunit that might specify PP1 to TAK1, we focused on several regulatory subunits of PP1 that appear to be induced after LPS treatment in macrophages. We overexpressed TAK1 together with each of the candidates to see which would coimmunoprecipitate with TAK1 and thus would mediate PP1 interaction with TAK1. Coimmunoprecipitation assay showed the strong interaction between TAK1 and GADD34. Ppp1r15b, but not others, also showed weak interaction with TAK1 ( Fig. 4A-B) . GADD34 directly interacted with TAK1, as GST-TAK1 was able to pull down MBP-GADD34 but not MBP-Ppp1cc, all of which were expressed and purified from E.coli (Fig. 4C) . We next mapped the region of GADD34 that interacts with TAK1 by using various HA-tagged truncation mutants of GADD34, which were constructed according to its structure and functional domains (32) . Coimmunoprecipitation revealed that the region spanning 242-540 of GADD34, which is N-terminal to the motif mediating the binding of GADD34 to PP1 (Fig. 4D) , is sufficient for TAK1 binding (Fig. 4E) . Consistent with our hypothesis that GADD34 mediates PP1 interaction with TAK1 and should function as a negative regulator of TAK1 activation, siRNA-mediated knockdown of GADD34 in primary peritoneal macrophages (Fig. 5A ) enhanced LPS-induced TAK1 Ser412 phosphorylation, but had no detectable effect on IRAK1 phosphorylation, which is similar to what we observed in the case of PP1 knockdown (Fig. 2C) .
We then asked whether GADD34 indeed mediates the interaction between PP1 and TAK1. An Ab against TAK1 was able to coimmunoprecipitate endogenous TAK1 and PP1. This interaction was abolished when GADD34 was depleted with siRNA ( Fig. 5B) . More notably, PP1 overexpression inhibited LPS-induced IkBa, JNK, and p38 phosphorylation, but this effect was blocked by simultaneous knockdown of GADD34 (Fig. 5C) . Accordingly, diminishment of IL-6 and TNF-a induction by PP1 overexpression in LPS-treated RAW264.7 cells was abolished when GADD34 was knocked down simultaneously (Fig. 5D) .
The interaction of PP1 with TAK1 is dynamic and can be disrupted upon stimulation (Fig. 3A-B) . We wondered whether the interaction between GADD34 and TAK1 is also dynamic. Coimmunoprecipitation experiments using either GADD34-specific or TAK1-specific Abs revealed that GADD34 and TAK1 exist as a complex under basal conditions, and their association is unaffected by LPS stimulation in RAW264.7 cells (Fig. 5E) . Collectively, GADD34 is the regulatory subunit of PP1 to specify PP1 to dephosphorylate TAK1 Ser412.
GADD34 negatively regulates TLR signaling and cytokine production
We further characterized the effects of GADD34 on TLR signaling. Overexpression of GADD34 reduced LPS-induced phosphorylation in RAW264.7 cells of IKKa/b, IkBa, ERK, JNK, and p38; this was not seen with GADD34DC, a C-terminal truncation mutant of GADD34 that cannot form complex with PPP1C (32) (Fig. 6A) . Accordingly, overexpression of GADD34, but not the GADD34DC, reduced IL-6 and TNF-a production in RAW264.7 cells induced by LPS, poly-IC, or CpG ODN (Fig. 6B) . Consistent with these results, knockdown of GADD34 in primary peritoneal macrophages (Figs. 6C-6D ) strongly enhanced LPS-induced phosphorylation of IKKa/b, IkBa, ERK, JNK, and p38, and significantly increased cytokine production. To confirm that negative regulation of TLR signaling by GADD34 is mediated by TAK1 Ser412 dephosphorylation, we tested whether the TAK1 S412D mutant is insensitive to regulation by GADD34. Overexpression of GADD34 in RAW264.7 cells strongly inhibited LPS-induced phosphorylation of IKKa/b, IkBa, ERK, JNK, and p38 even when coexpressed with TAK1 WT, which alone slightly enhanced their phosphorylation (Fig. 6E) . In contrast, when TAK1 S412D was used, overexpression of GADD34 did not inhibit LPS-induced phosphorylation of IKKa/b, IkBa, ERK, JNK, or p38 (Fig. 6E) . In addition, overexpression of GADD34 inhibited IL-6 and TNF-a production, and this inhibition was abolished in the presence of coexpressed TAK1 S412D (Fig. 6F) . Therefore, like PP1, GADD34 also negatively regulates TLR signaling through inhibiting Ser412 phosphorylation.
TAK1 Ser412 phosphorylation is essential for TLR signaling and cytokine production
It is well known that phosphorylation of Thr187 is required for TAK1 kinase activation and is necessary for TLR triggered signaling (20, 21) . TAK1 Ser412 phosphorylation has been described in only two reports (22, 23) , and the role of TAK1 Ser412 phosphorylation in TLRs triggered immune response had not been reported. We stimulated a number of cells and cell lines, including freshly prepared peritoneal macrophages, RAW264.7 cell line, mouse embryonic fibroblast (MEF) cell line and C6 cell line (a 293 derivative stably expressing IL-1R) with LPS and IL-1b, and detected TAK1 Ser412 phosphorylation with TAK1 phosphoSer412 specific Ab. As seen with stimulation-dependent Thr187 phosphorylation, the treatment induced phosphorylation of Ser412 (Fig. 7A) . These two phosphorylation events correlate well with each other and suggest that TAK1 Ser412 phosphorylation might be a common event in response to LPS and IL-1b stimulation in various cell types.
We next investigated the significance of phosphorylation of TAK1 Ser412 in the NF-kB and MAPK signaling pathways. LPS treatment of RAW264.7 cells resulted in TAK1 activation, which in turn led to phosphorylation of IkBa, p38, JNK, and ERK1/2 (Fig. 7B) . Overexpression of TAK1 WT slightly enhanced phosphorylation of IkBa, p38, JNK, and ERK1/2. In contrast, overexpression of TAK1 Ser412 to alanine (S412A) mutant significantly inhibited phosphorylation of IkBa, p38, JNK, and ERK1/2. The inhibition by TAK1 (S412A) was comparable to the reduction induced by overexpression of TAK1 (K63W) and TAK1 (T187A), two known TAK1 kinase-dead mutants that can function as dominant-negative mutants (Fig. 7B) . Knockdown of TAK1 using hTAK1-specific small RNA in C6 cells reduced IL-1b-induced phosphorylation of IkBa, p38, and JNK, which was rescued by simultaneous expression of mTAK1 WT, but not T187A or S412A mutants ( Supplemental Fig. 3A) . Overexpression of TAK1 T187A, S412A, or K63W, but not WT in RAW264.7 cells also reduced production of IL-6 and TNF-a in response to LPS, poly-IC, or CpG treatment (Fig. 7C) . MEFs generated from Cremediated TAK1 knockout cells showed impaired phosphorylation of IkBa, JNK, p38, and ERK1/2 and production of cytokines following LPS treatment (Fig. 7D-E) , which was rescued to a comparable level to WT MEFs upon overexpression of TAK1 WT, T187D, S412D, or T187D/S412D, but not T187A, S412A, or T187A/S412A (Fig. 7D-E) . The T187D and S412D mutations mimic their phosphorylation, rendering them insensitive to regulation of dephosphorylation. The residual phosphorylation of these proteins in knockout MEF cells might be due to incomplete knockout of TAK1 (Supplemental Fig. 3B) . Measurement of IL-6 and TNF-a mRNA induction using quantitative RT-PCR revealed similar results (Supplemental Fig. 3C ). These data together suggest that TAK1 Ser412 is phosphorylated in response to TLR and IL-1R activation and required for downstream signaling and cytokine induction.
Discussion
TLRs have critical roles in host defense against infection by detecting conserved components of invading microbial pathogens. Although TLRs are crucial for the initiation of protective immune responses, inappropriate TLR responses can contribute to the pathogenesis of acute and chronic inflammation, as well as to systemic autoimmune diseases. Thus, exploring how TLR signaling is tightly regulated would help us to understand the immunologic balance between activation and inhibition to avoid inappropriate inflammatory responses. In this report, we demonstrate that phosphatase PP1 negatively regulated TLR-triggered innate immune responses. PP1 knockdown increased LPS-induced proinflammatory cytokine production in macrophages. Inhibition of PP1 with a small molecule inhibitor led to enhancement of TNF-a production and susceptibility to endotoxin shock in mice. Therefore, PP1 serves as a physiologic inhibitor of TLR signaling, which can prevent excessive activation of TLRs and protect the host from overwhelmed inflammatory immune responses.
TAK1 is the upstream kinase whose kinase activity is required in the IL-1R/TLR signaling pathways. Its activation leads to phosphorylation and activation of IKK-NF-kB and the three MAP kinase pathways, which lead to the production of proinflammatory cytokines (33) . Phosphorylation of Thr187 is necessary for TAK1 kinase activity on its downstream substrates and cytokine induction in TLR pathway (20) . TAK1 Ser412 phosphorylation was reported previously (22, 23) . However, the importance of Ser412 phosphorylation in TAK1 activation, and its role in the TLR and IL-1R pathways, was unknown. In this study, we found that PP1 and its regulatory subunit GADD34 negatively regulated TLRtriggered immune response by dephosphorylating TAK1 Ser412 instead of Thr187. In fact, PP1 did not show any detectable phosphatase activity toward Thr187 in an in vitro assay using purified PP1 and preactivated TAK1. We also found that in multiple cell types, stimulation of IL-1R or TLRs results in rapid phosphorylation, followed by dephosphorylation, of TAK1 Ser412. This finding suggests that TAK1 Ser412 phosphorylation is not unique to a particular cell type or a particular ligand, but instead plays a general role in the TLR and IL-1R pathways. Our data then demonstrate that Ser412 phosphorylation is as important as Thr187 phosphorylation for TAK1 kinase activation (20) . Overexpression of either of these mutants had a dominant negative effect. Interestingly, although both residues are important for TAK1 kinase activation, and their phosphorylation profiles show parallel kinetics, it seems that Thr187 phosphorylation and Ser412 phosphorylation are actually independent of each other.
Thr187 is located in the TAK1 kinase activation loop; by contrast, Ser412 is near the C terminus, which is rather distant from the kinase domain. It is not clear how Ser412 phosphorylation influences TAK1 kinase activity; an understanding of this will require structural information. Notably, activation of many kinases, such as Akt, NDR, and PKC family members, requires phosphorylation of Ser/Thr residues outside of their respective activation loops for maximal activity (34) . For example, full AKT activation requires phosphorylation of the hydrophobic segment at its C terminus by mTORC2 (35) .
A previous report has shown that PP1/GADD34/CUEDC2 dephosphorylates IKK and regulates cytokine production in the TNF-a pathway (18) . We presented several lines of evidence suggesting that the most important target of PP1 in the IL-1R and TLR signaling pathways tested in this study is TAK1.
The Journal of Immunology 1. In our in vitro phosphatase assay, PP1 did not show potent activity on IKK. 2. Using NF-kB-based reporter assays, epistatic analysis showed that PP1 functions at the level of TAK1. 3. Overexpression or knockdown of PP1 or GADD34 affected both NF-kB and MAP kinase signaling components instead of just IKK and its downstream IkBa. 4. The negative regulatory effects of PP1 and GADD34 were abolished by simultaneous expression of TAK1 S412D mutant.
The target of tautomycetin inhibition also includes other proteins, such as SHP2 (36) , which negatively regulates the TRIF adaptor protein-dependent type I IFN and proinflammatory cytokine production in TLR signaling (8) . It is hard to exclude the possibility that the tautomycetin aggravates LPS-induced endotoxin shock in mice via inhibiting SHP2 activity. Because the IC 50 values for PP1 and SHP2 enzymes is 1.6 nM and 2.9 mM, respectively (27, 36) . The dominant inhibition target of tautomycetin should be PP1 in the mouse model. In summary, we have shown that PP1 is a feedback-negative regulator of TLR signaling by targeting TAK1 at Ser412 residue. The phosphorylation of TAK1 at Ser412 kinase is required for full activation of TAK1 and downstream signaling in the IL-1R and TLRs pathways. PP1, together with its regulatory subunit GADD34, associates with TAK1 in resting cells, disassociates from TAK1 upon ligand stimulation, and quickly associates with TAK1 again. The cycling of association and disassociation between TAK1 and PP1 thus tightly controls TAK1 Ser412 phosphorylation and its activation, regulating the magnitude and duration of the IL-1R and TLR signaling (Supplemental Fig. 4 ).
Corrections
Gu, M., C. Ouyang, W. Lin, T. Zhang, X. Cao, Z. Xia, and X. Wang. 2014. Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation. J. Immunol. 192: 2846-2856.
In the original Fig.7B , a blot of p-JNK was used to represent p-ERK1/2 by mistake. In the original Fig.7D , the two right panels for ERK1/2 were inadvertently duplicated. (B) Lysates from MEFs used in Figure 7D were subjected to immunoblotting to confirm the efficiency of Cre-mediated TAK1 knockout.
(C) As in Figure 7E , but cells were stimulated with LPS for 6 or 24 hours. mRNAs were then extracted and used to determine induction of IL-6 and TNF-α by using quantitative real-time PCR (Q-RT-PCR). Data are plotted as means ± SE; ＊p < 0.05, ＊＊p < 0.01, ＊＊＊p < 0.001, versus controls. All experiments were performed at least three times. 
